Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
The Journal of Infection|August 6, 2025
Evolutionary dynamics of HRSV following the implementation of nirsevimab immunoprophylaxis in Catalonia (2023-2024)Alejandra González-Sánchez, Cristina Andrés, Ignasi Prats-Méndez, et al.
JAMA Network Open|April 12, 2024
Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With NatalizumabRené Carvajal, Ana Zabalza, Pere Carbonell-Mirabent, et al.
JAMA Network Open|May 20, 2026
Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis ActivityRené Carvajal, Marta Ponzano, Carmen Tur, et al.
Kidney International|February 6, 2022
A comprehensive assessment of long-term SARS-CoV-2-specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipientsAlexandre Favà, Laura Donadeu, Thomas Jouve, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 19, 2026
Exhausted/Senescent CD4<sup>+</sup> T cells as Predictors of Vaccine Failure and Severe COVID-19 in Solid Organ Transplant RecipientsLaura Donadeu, Franc Casanova-Ferrer, Susana Gomez-Olles, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 2, 2022
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple SclerosisAna Zabalza, Georgina Arrambide, Paula Tagliani, et al.
Frontiers in Immunology|October 23, 2024
Role of SARS-CoV-2-specific memory B cells promoting immune protection after booster vaccination in solid organ transplantationLaura Donadeu, Susana Gomez-Olles, Franc Casanova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 27, 2022
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?Ana Zabalza, Georgina Arrambide, Susana Otero-Romero, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|November 3, 2025
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC: GEPI, GeSIDA, GESITRA-IC, GEIRAS) on screening for imported infectious diseases in immunocompromised patientsMaría Velasco, María-Delmans Flores-Chávez, Jara Llenas-García, et al.
Pageof 9